Literature DB >> 17351427

Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.

Andreas Stadlbauer1, Christopher Nimsky, Rolf Buslei, Katja Pinker, Stephan Gruber, Thilo Hammen, Michael Buchfelder, Oliver Ganslandt.   

Abstract

PURPOSE: We sought to retrospectively investigate differences in correlation of absolute metabolites concentrations and metabolite ratios with histopathologic parameters of stereotactic biopsies from the border zone of gliomas.
MATERIALS AND METHODS: Proton magnetic resonance spectroscopic imaging (H-MRSI) with high spatial resolution was performed in 10 glioma patients at 1.5 T. Magnetic resonance spectroscopic imaging (MRSI) data were coregistered to a 3D MR data set used for stereotactic procedures. Metabolite concentrations of choline-containing compounds (Cho), creatine (Cr), and total N-acetyl-aspartate (tNAA) in addition to metabolite ratios of Cho/Cr, tNAA/Cr, and Cho/tNAA were calculated for voxel positions at biopsy loci with low tumor cell infiltration. Metabolite values were correlated with histopathologic findings expressed as a relative (% tumor infiltration, %TI) and an absolute parameter (tumor cell number, TCN).
RESULTS: We found a strong negative linear correlation for tNAA with %TI (R = -0.773, P < 0.001) and TCN (R = -0.769, P < 0.001) but no correlation for Cho (P > 0.05). On the other hand, the metabolite ratio of Cho/Cr showed a moderate positive linear correlation with %TI (R = 0.523, P = 0.012) and TCN (R = 0.486, P = 0.019), but no correlation was obtained for tNAA/Cr (P > 0.05). Differences in correlation between tNAA and Cho as well as tNAA/Cr and Cho/Cr were significant for both %TI (P = 0.012 and P = 0.024) and TCN (P = 0.016 and P = 0.040) using a t test.
CONCLUSIONS: We conclude that absolute values of tNAA are more significant than Cho in the detection of low tumor cell infiltration. On the basis of absolute metabolite values, neuronal damage seems to be more distinct than cell membrane proliferation in the border zone of gliomas. Furthermore, the calculation of metabolite ratios versus Cr for the border zone may yield to misleading results because Cr is not constant in this area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351427     DOI: 10.1097/01.rli.0000255812.61435.67

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  12 in total

1.  The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.

Authors:  Jun Guo; Chengjun Yao; Hong Chen; Dongxiao Zhuang; Weijun Tang; Guang Ren; Yin Wang; Jinsong Wu; Fengping Huang; Liangfu Zhou
Journal:  Acta Neurochir (Wien)       Date:  2012-06-23       Impact factor: 2.216

2.  Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.

Authors:  James S Cordova; Hui-Kuo G Shu; Zhongxing Liang; Saumya S Gurbani; Lee A D Cooper; Chad A Holder; Jeffrey J Olson; Brad Kairdolf; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Hyunsuk Shim
Journal:  Neuro Oncol       Date:  2016-03-15       Impact factor: 12.300

3.  Spatial Relationship of Glioma Volume Derived from 18F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI Study.

Authors:  Jörg Mauler; Andrew A Maudsley; Karl-Josef Langen; Omid Nikoubashman; Gabriele Stoffels; Sulaiman Sheriff; Philipp Lohmann; Christian Filss; Norbert Galldiks; Elena Rota Kops; N Jon Shah
Journal:  J Nucl Med       Date:  2017-08-28       Impact factor: 10.057

4.  High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7T.

Authors:  Gilbert Hangel; Saurabh Jain; Elisabeth Springer; Eva Hečková; Bernhard Strasser; Michal Považan; Stephan Gruber; Georg Widhalm; Barbara Kiesel; Julia Furtner; Matthias Preusser; Thomas Roetzer; Siegfried Trattnig; Diana M Sima; Dirk Smeets; Wolfgang Bogner
Journal:  Neuroimage       Date:  2019-02-14       Impact factor: 6.556

Review 5.  Imaging of brain tumors: MR spectroscopy and metabolic imaging.

Authors:  Alena Horská; Peter B Barker
Journal:  Neuroimaging Clin N Am       Date:  2010-08       Impact factor: 2.264

Review 6.  Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor.

Authors:  Hyunsuk Shim; Li Wei; Chad A Holder; Ying Guo; Xiaoping P Hu; Andrew H Miller; Jeffrey J Olson
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

7.  Hints on new applications of emission tomography and magnetic resonance in neuro-oncology.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08       Impact factor: 10.057

8.  A systematic pipeline for the objective comparison of whole-brain spectroscopic MRI with histology in biopsy specimens from grade III glioma.

Authors:  J Scott Cordova; Saumya S Gurbani; Jeffrey J Olson; Zhongxing Liang; Lee A D Cooper; Hui-Kuo G Shu; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Chad A Holder; Hyunsuk Shim
Journal:  Tomography       Date:  2016-06

9.  Comparison among conventional and advanced MRI, 18F-FDG PET/CT, phenotype and genotype in glioblastoma.

Authors:  Maria Consuelo Valentini; Marta Mellai; Laura Annovazzi; Antonio Melcarne; Tetyana Denysenko; Paola Cassoni; Cristina Casalone; Cristiana Maurella; Silvia Grifoni; Piercarlo Fania; Angelina Cistaro; Davide Schiffer
Journal:  Oncotarget       Date:  2017-10-04

10.  Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.

Authors:  J Scott Cordova; Shravan Kandula; Saumya Gurbani; Jim Zhong; Mital Tejani; Oluwatosin Kayode; Kirtesh Patel; Roshan Prabhu; Eduard Schreibmann; Ian Crocker; Chad A Holder; Hyunsuk Shim; Hui-Kuo Shu
Journal:  Tomography       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.